Final Thoughts on Clinical Advances in MDS and CML

Final Thoughts on Clinical Advances in MDS and CML

In the final segment, moderator Harry P. Erba, MD, PhD, asks each panelist to provide their final thoughts on recent advances in the treatment of patients with myelodysplastic syndromes and chronic myeloid leukemia. To view the rest of the discussion, visit http://www.onclive.com/peer-exchange/...